Evidence from a Randomized Trial That Simvastatin, but Not Ezetimibe, Upregulates Circulating PCSK9 Levels

Overview of attention for article published in PLOS ONE, March 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

f1000: 1 research highlight platform

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Research highlights Dimensions citations

So far, Dimensions has found 55 publications that cite this research output.

55

The most recent citing publications are shown below. View all 55 publications that cite this research output on Dimensions.

Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9

Article in Journal of Lipid Research (February 2024)

Geranylgeranyl Isoprenoids and Hepatic Rap1a Regulate Basal and Statin-Induced Expression of PCSK9

Preprint in bioRxiv (October 2023)

Is Our Increasing Understanding of PCSK9 and Lp(a) Metabolism the Key to Unlocking the Paradox of Statins Ineffectiveness in Reducing Cardiovascular Events in Advanced CKD?

Article in SN Comprehensive Clinical Medicine (July 2022)